Dr Peter Pockney
Senior Lecturer
School of Medicine and Public Health (Medicine)
- Email:peter.pockney@newcastle.edu.au
- Phone:(02) 4985 5527
Career Summary
Biography
Dr Peter Pockney has been the Senior Lecturer in Surgery at the University of Newcastle since 2011. In this role, he combines an active teaching and research commitment to the School of Medicine and Public Health with clinical practice as a specialist colorectal, general and trauma surgeon at the John Hunter Hospital, Newcastle.
Peter completed undergraduate medicine at University College London in 1996, graduating with Distinction in Surgery and Merit in Medicine. He did basic clinical training at University College London, Southampton University Hospitals and Cambridge University Hospitals before completing his Doctorate of Medicine in 2004 at Southampton University under the Supervision of Professor John Primrose. This research was in the field of surgical randomised clinical trials, which remained the main focus of his research activity until 2016.
After finishing research training and his DM, Peter completed higher surgical training in 2007, specialising in General and Colorectal surgery. A subspecialty fellowship in Newcastle, NSW in 2008 was followed by 2 years working as a Consultant Surgeon in London.
Peter returned to Newcastle as the Senior Lecturer in Surgery in 2011. He has the role of course coordinator for surgery in the BMed, which includes responsibility for course and assessment design, and approximately 10 hours a week contact time teaching with the students.
His research activity has included being the Chief Investigator and contributor to 5 randomised clinical trials aimed at improving outcomes after major colorectal surgery, and three prospective studies of biomarkers as indicators of adverse events in surgery. He has also led a major project in service redesign to improve access to colonoscopy for people at high risk of bowel cancer, and a further study that improved cost effectiveness and efficiency in the operating theatre during common surgical procedures.
In 2016 he led an initiative that brought together the Hunter New England Local Health District and the University of Newcastle to support 4 Junior Clinical Fellows in Surgical Research and Teaching. These Fellows are funded through part-time work for the hospital to teach undergraduate students and to conduct high quality research. The projects being undertaken include examining the role of circulating cell free tumour DNA as a biomarker for colorectal cancer, the role of Neutrophil Extracellular Traps in colorectal cancer metastases, neurotrophic growth factors in prostate cancer, a randomised clinical trial of prehabilitation in major upper gastrointestinal surgery, and a multicentre audit of emergency laparotomy operations.
This program is being extended in 2018, with 12 positions being offered across General and Colorectal Surgery, Neurosurgery, Cardiothoracic surgery and Trauma surgery. Other projects being undertaken under his supervision include examining the role of the colonic microbiome in anastomotic leaks, the utility of a biomarker in diagnosis of acute appendicitis, and the role of variations in the genome of CD36 in the phenotype of Familial Adenomatous Polyposis.
Membership
Royal Australasian College of Surgeons, Section of Academic Surgeons
Colorectal Surgical Society of Australia and New Zealand
Qualifications
- Doctor of Medicine, University of Southampton - UK
- Bachelor of Science (Honours)(Geography), University of Exeter - UK
- Bachelor of Medicine, Bachelor of Surgery, University of London
- Post Graduate Cert-Completion of Train(Gen Surgery, Post Graduate Medical Educ & Training Board - UK
Keywords
- Clinical Trials
- Colorectal Cancer
- Colorectal Cancer Screening
- Colorectal Surgery
- FAP
- Neutrophil Extracellular Traps
Fields of Research
| Code | Description | Percentage |
|---|---|---|
| 080799 | Library and Information Studies not elsewhere classified | 30 |
| 110399 | Clinical Sciences not elsewhere classified | 35 |
| 111799 | Public Health and Health Services not elsewhere classified | 35 |
Professional Experience
UON Appointment
| Title | Organisation / Department |
|---|---|
| Senior Lecturer | University of Newcastle School of Medicine and Public Health Australia |
| Senior Lecturer | Priority Research Centre (PRC) for Healthy Lungs | The University of Newcastle School of Medicine and Public Health Australia |
| Senior Lecturer | University of Newcastle School of Medicine and Public Health Australia |
Professional appointment
| Dates | Title | Organisation / Department |
|---|---|---|
| 11/01/2011 - 21/07/2028 |
Consultant Surgeon Consultant Colorectal and General Surgeon. |
John Hunter Hospital, Newcastle Colorectal Surgery Australia |
Publications
For publications that are currently unpublished or in-press, details are shown in italics.
Chapter (1 outputs)
| Year | Citation | Altmetrics | Link | |||||
|---|---|---|---|---|---|---|---|---|
| 2019 |
Gould T, Jamaluddin M, Petit J, King SJ, Nixon B, Scott R, et al., 'Finding Needles in Haystacks: The Use of Quantitative Proteomics for the Early Detection of Colorectal Cancer', Advances in the Molecular Understanding of Colorectal Cancer, IntechOpen, Switzerland 1-32 (2019) [B1]
|
|||||||
Journal article (31 outputs)
| Year | Citation | Altmetrics | Link | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 |
Petit J, Carroll G, Gould T, Pockney P, Dun M, Scott RJ, 'Cell-free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review', Journal of Surgical Research, 236 184-197 (2019) © 2018 Elsevier Inc. Background: Circulating tumour DNA (ctDNA) has emerged as an excellent candidate for the future of liquid biopsies for many cancers. There has been growing in... [more] © 2018 Elsevier Inc. Background: Circulating tumour DNA (ctDNA) has emerged as an excellent candidate for the future of liquid biopsies for many cancers. There has been growing interest in blood-based liquid biopsy because of the potential of ctDNA to produce a noninvasive test that can be used for: the diagnosis of colorectal cancer, monitoring therapy response, and providing information on overall prognosis. The aim of this review was to collate and explore the current evidence regarding ctDNA as a screening tool for colorectal cancer (CRC). Methods: A systematic review of published articles in English over the past 20 y was performed using Medline, Embase, and Cochrane databases on May 23, 2017. After a full-text review, a total of 69 studies were included. Two assessment tools were used to review and compare the methodological quality of these studies. Results: Among the 69 studies included, 17 studies reviewed total cfDNA, whereas six studies looked at the DNA integrity index and 15 focused on ctDNA. There were a total of 40 studies that reviewed methylated cfDNA with 19 of these focussing specifically on SEPT9. Conclusions: The results of this review indicate that methylated epigenetic ctDNA markers are perhaps the most promising candidates for a blood-based CRC-screening modality using cell-free (cf) DNA. Methylated cfDNA appears to be less specific for CRC compared to ctDNA; however, they have demonstrated good sensitivity for early-stage CRC. Further research is required to determine which methylated cfDNA markers are the most accurate when applied to large cohorts of patients. In addition, reliable comparison of results across multiple studies would benefit from standardization of methodology for DNA extraction and PCR techniques in the future.
|
||||||||||
| 2018 |
Smith SR, Murray D, Pockney PG, Bendinelli C, Draganic BD, Carroll R, 'Tranexamic Acid for Lower GI Hemorrhage: A Randomized Placebo-Controlled Clinical Trial', Diseases of the Colon and Rectum, 61 99-106 (2018) [C1] © 2017 The American Society of Colon and Rectal Surgeons, Inc. BACKGROUND: Lower GI hemorrhage is a common source of morbidity and mortality. Tranexamic acid is an antifibrinolyti... [more] © 2017 The American Society of Colon and Rectal Surgeons, Inc. BACKGROUND: Lower GI hemorrhage is a common source of morbidity and mortality. Tranexamic acid is an antifibrinolytic that has been shown to reduce blood loss in a variety of clinical conditions. Information regarding the use of tranexamic acid in treating lower GI hemorrhage is lacking. OBJECTIVE: The aim of this trial was to determine the clinical efficacy of tranexamic acid when used for lower GI hemorrhage. DESIGN: This was a prospective, double-blind, placebo-controlled, randomized clinical trial. SETTINGS: The study was conducted at a tertiary referral university hospital in Australia. PATIENTS: Consecutive patients aged >18 years with lower GI hemorrhage requiring hospital admission from November 2011 to January 2014 were screened for trial eligibility (N = 265). INTERVENTIONS: A total of 100 patients were recruited after exclusions and were randomly assigned 1:1 to either tranexamic acid or placebo. MAIN OUTCOME MEASURES: The primary outcome was blood loss as determined by reduction in hemoglobin levels. The secondary outcomes were transfusion rates, transfusion volume, intervention rates for bleeding, length of hospital stay, readmission, and complication rates. RESULTS: There was no difference between groups with respect to hemoglobin drop (11 g/L of tranexamic acid vs 13 g/L of placebo; p = 0.9445). There was no difference with respect to transfusion rates (14/49 tranexamic acid vs 16/47 placebo; p = 0.661), mean transfusion volume (1.27 vs 1.93 units; p = 0.355), intervention rates (7/49 vs 13/47; p = 0.134), length of hospital stay (4.67 vs 4.74 d; p = 0.934), readmission, or complication rates. No complications occurred as a direct result of tranexamic acid use. LIMITATIONS: A larger multicenter trial may be required to determine whether there are more subtle advantages with tranexamic acid use in some of the secondary outcomes. CONCLUSIONS: Tranexamic acid does not appear to decrease blood loss or improve clinical outcomes in patients presenting with lower GI hemorrhage in the context of this trial. see Video Abstract at http://links.lww.com/DCR/A453.
|
||||||||||
| 2018 |
Almazi JG, Pockney P, Gedye C, Smith ND, Hondermarck H, Verrills NM, Dun MD, 'Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal Cancer.', Proteomics. Clinical applications, 12 e1700121 (2018) [C1]
|
||||||||||
| 2018 |
Clarke L, Pockney P, Gillies D, Foster R, Gani J, 'Direct Access Colonoscopy Service for Bowel Cancer Screening produces a positive financial benefit for patients and Local Health Districts.', Internal medicine journal, (2018)
|
||||||||||
| 2018 |
Clarke L, Pockney P, Gillies D, Foster R, Gani J, 'Time to colonoscopy for patients accessing the Direct Access Colonoscopy Service compared to the normal service in Newcastle, Australia.', Internal medicine journal, (2018)
|
||||||||||
| 2018 |
Smith SR, Pockney P, Holmes R, Doig F, Attia J, Holliday E, et al., 'Biomarkers and anastomotic leakage in colorectal surgery: C-reactive protein trajectory is the gold standard.', ANZ journal of surgery, 88 440-444 (2018) [C1]
|
||||||||||
| 2018 |
March B, Leigh L, Brussius-Coelho M, Holmes M, Pockney P, Gani J, 'Can CRP velocity in right iliac fossa pain identify patients for intervention? A prospective observational cohort study', Surgeon, (2018) © 2018 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland Introduction: Previous studies have shown single CRP meas... [more] © 2018 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland Introduction: Previous studies have shown single CRP measurements at time of presentation to have limited predictive benefit for appendicitis. Our objective was to determine the diagnostic utility of serial CRP measurements (to determine CRP velocity [CRPv]) in patients with right iliac fossa (RIF) pain. Methods: A single-centre prospective observational study was conducted on adult patients admitted with RIF pain. CRP was measured on admission, at midnight, and the following morning. Appendicitis was diagnosed on histopathology, or diagnostic imaging in non-operatively managed patients. Therapeutic interventions included all appropriate operative procedures and effective non-operative treatment with antibiotics. Logistic regression was used to generate predictors of therapeutic intervention, and then used to create a new risk score incorporating CRPv. Results: 98 of 112 (87.5%) participants had complete CRP data. 58 patients met the criteria for appendicitis (59.2%). Most patients presented with intermediate Modified Alvarado Scores (MAS) 5¿6 (40.8%) or Appendicitis Inflammatory Response Scores (AIRS) 5¿8 (49%). Our risk score had an AUROC of 0.88 (95% CI 0.81¿0.96) in predicting therapeutic intervention. This score was superior to MAS, AIRS, and single admission biomarker measurements. Patients with an increasing CRPv had 14 times the odds (OR 14.07, 95% CI 0.63¿315.2) of complicated appendicitis, and no cases of complicated appendicitis were observed in patients with a flat CRPv. Conclusions: CRP velocity is superior to single CRP at predicting intervention. Our v-Score shows promise as a decision making-aide by predicting the need for surgical intervention in RIF pain. A flat CRPv identifies a group of patients with a very low risk of complicated appendicitis.
|
||||||||||
| 2018 |
Holmes R, Smith SR, Carroll R, Holz P, Mehrotra R, Pockney P, 'Randomized clinical trial to assess the ideal mode of delivery for local anaesthetic abdominal wall blocks.', ANZ journal of surgery, 88 786-791 (2018) [C1]
|
||||||||||
| 2018 |
Holmes M, Connor T, Oldmeadow C, Pockney PG, Scott RJ, Talseth-Palmer BA, 'CD36-a plausible modifier of disease phenotype in familial adenomatous polyposis', HEREDITARY CANCER IN CLINICAL PRACTICE, 16 (2018) [C1]
|
||||||||||
| 2017 |
Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al., 'Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases', Annals of Surgery, 266 111-117 (2017) [C1] Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. Objective: This study aims to report short-term clinical and oncological outcomes from the international transana... [more] Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. Objective: This study aims to report short-term clinical and oncological outcomes from the international transanal Total Mesorectal Excision (taTME) registry for benign and malignant rectal pathology. Background: TaTME is the latest minimally invasive transanal technique pioneered to facilitate difficult pelvic dissections. Outcomes have been published from small cohorts, but larger series can further assess the safety and efficacy of taTME in the wider surgical population. Methods: Data were analyzed from 66 registered units in 23 countries. The primary endpoint was "good-quality TME surgery." Secondary endpoints were short-term adverse events. Univariate and multivariate regression analyses were used to identify independent predictors of poor specimen outcome. Results: A total of 720 consecutively registered cases were analyzed comprising 634 patients with rectal cancer and 86 with benign pathology. Approximately, 67% were males with mean BMI 26.5 kg/m 2. Abdominal or perineal conversion was 6.3% and 2.8%, respectively. Intact TME specimens were achieved in 85%, with minor defects in 11% and major defects in 4%. R1 resection rate was 2.7%. Postoperative mortality and morbidity were 0.5% and 32.6% respectively. Risk factors for poor specimen outcome (suboptimal TME specimen, perforation, and/or R1 resection) on multivariate analysis were positive CRM on staging MRI, low rectal tumor <2 cm from anorectal junction, and laparoscopic transabdominal posterior dissection to <4 cm from anal verge. Conclusions: TaTME appears to be an oncologically safe and effective technique for distal mesorectal dissection with acceptable short-term patient outcomes and good specimen quality. Ongoing structured training and the upcoming randomized controlled trials are needed to assess the technique further.
|
||||||||||
| 2017 |
Schmiegel W, Scott RJ, Dooley S, Lewis W, Meldrum CJ, Pockney P, et al., 'Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing', MOLECULAR ONCOLOGY, 11 208-219 (2017) [C1]
|
||||||||||
| 2015 |
Smith S, Pockney P, Attia J, 'Corrigendum: A Meta-analysis on the Effect of Sham Feeding Following Colectomy: Should Gum Chewing Be Included in Enhanced Recovery After Surgery Protocols?', Diseases of the colon and rectum, 58 e416 (2015) [O1]
|
||||||||||
| 2015 |
Smith SR, Draganic B, Pockney P, Holz P, Holmes R, Mcmanus B, Carroll R, 'Transversus abdominis plane blockade in laparoscopic colorectal surgery: a double-blind randomized clinical trial', INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 30 1237-1245 (2015) [C1]
|
||||||||||
| 2014 |
Ho YM, Smith SR, Pockney P, Lim P, Attia J, 'A Meta-analysis on the Effect of Sham Feeding Following Colectomy: Should Gum Chewing Be Included in Enhanced Recovery After Surgery Protocols?', DISEASES OF THE COLON & RECTUM, 57 115-126 (2014) [C1]
|
||||||||||
| 2010 |
Reid K, Pockney P, Draganic B, Smith S, 'Barrier wound protection decreases surgical site infection in open elective colorectal surgery: A randomized clinical trial', Diseases of the Colon & Rectum, 53 1374-1380 (2010) [C1]
|
||||||||||
| Show 28 more journal articles | |||||||||||
Conference (7 outputs)
| Year | Citation | Altmetrics | Link | |||||
|---|---|---|---|---|---|---|---|---|
| 2018 |
Petit J, Pockney P, Scott R, 'Methylation Specific Droplet Digital PCR Accurately Quantifies BCAT1 Allele in Colorectal Cancer Patients', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
|
|||||||
| 2018 |
Gould T, Jamaluddin MFB, Pockney P, Dun M, 'Quantitative Proteomics for the Early Detection of Colorectal Cancer', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
|
|||||||
| 2016 |
Al Mazi JT, Verrills N, Smith N, Pockney P, Hondermarck H, Dun M, 'A COMPARISON BETWEEN DATA-DEPENDENT ANALYSIS AND HIGH-RESOLUTION ACCURATE MASS TARGETED PROTEOMICS APPROACHES FOR THE QUANTIFICATION OF PLASMA BIOMARKERS IN COLORECTAL CANCER', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2016)
|
|||||||
| 2015 |
Scott R, Dooley S, Lewis W, Meldrum C, Pockney P, Draganic B, et al., 'Concordance of RAS mutation status in CRC patients by comparison of results from circulating tumour DNA and tissue-based testing', ANNALS OF ONCOLOGY, Barcelona, SPAIN (2015) [E3]
|
|||||||
| 2014 | Gillies D, Gani J, Foster R, Pockney P, Duggan A, 'FAST TRACK COLONOSCOPY FOR POSITIVE FAECAL OCCULT BLOOD TESTING ( plus FOBT) IN A PUBLIC HOSPITAL SETTING', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2014) | |||||||
| 2013 |
Grice DM, Bauer DC, Duesing K, Li D, Greenfield P, Nielsen S, et al., 'Human and microbial transcriptomics from lean and obese individuals with colorectal cancer: A comparison of Total and Poly A RNA sequencing from clinical samples.', CANCER RESEARCH, Washington, DC (2013) [E3]
|
|||||||
| Show 4 more conferences | ||||||||
Grants and Funding
Summary
| Number of grants | 22 |
|---|---|
| Total funding | $1,459,026 |
Click on a grant title below to expand the full details for that specific grant.
20194 grants / $384,388
Testing the impact of an Interactive Health Communication Application on days alive out of hospital and quality of life following surgery for colorectal cancer$298,835
Funding body: NHMRC (National Health & Medical Research Council)
| Funding body | NHMRC (National Health & Medical Research Council) |
|---|---|
| Project Team | Dr Stephen Smith, Laureate Professor Robert Sanson-Fisher, Conjoint Professor Jonathan Gani, Dr Jon Gani, Associate Professor Mariko Carey, Doctor Sancha Robinson, Sancha Robinson, Professor Andrew Searles, Conjoint Professor Andrew Searles, Doctor Peter Pockney, Doctor Christopher Oldmeadow, Mr Chris Oldmeadow, Conjoint Associate Professor Ross Kerridge |
| Scheme | Partnership Projects |
| Role | Investigator |
| Funding Start | 2019 |
| Funding Finish | 2023 |
| GNo | G1800929 |
| Type Of Funding | Aust Competitive - Commonwealth |
| Category | 1CS |
| UON | Y |
Hide and Seek with hereditary cancer: Improving detection of colorectal cancer patients with a high risk of Lynch Syndrome$43,688
Funding body: Cancer Council NSW
| Funding body | Cancer Council NSW |
|---|---|
| Project Team | Doctor Peter Pockney |
| Scheme | Research Grant |
| Role | Lead |
| Funding Start | 2019 |
| Funding Finish | 2020 |
| GNo | G1801224 |
| Type Of Funding | C3112 - Aust Not for profit |
| Category | 3112 |
| UON | Y |
HMRI MRSP Infrastructure Funding Cancer Program 2019$21,802
Funding body: NSW Ministry of Health
| Funding body | NSW Ministry of Health |
|---|---|
| Project Team | Conjoint Professor Stephen Ackland, Professor Xu Dong Zhang, Laureate Professor Rodney Scott, Associate Professor Nikki Verrills, Doctor Peter Pockney, Doctor Steve Smith, Doctor Liz Fradgley, Professor Amanda Baker, Doctor Jude Weidenhofer, Conjoint Professor Stephen Ackland |
| Scheme | Medical Research Support Program (MRSP) |
| Role | Investigator |
| Funding Start | 2019 |
| Funding Finish | 2019 |
| GNo | G1900048 |
| Type Of Funding | C2220 - Aust StateTerritoryLocal - Other |
| Category | 2220 |
| UON | Y |
Lignocaine infusion in Colerectal cancer Patient Immune Cells LICPIC Study$20,063
Funding body: John Hunter Hospital Charitable Trust
| Funding body | John Hunter Hospital Charitable Trust |
|---|---|
| Project Team | Doctor Peter Pockney |
| Scheme | Research Grant |
| Role | Lead |
| Funding Start | 2019 |
| Funding Finish | 2019 |
| GNo | G1900371 |
| Type Of Funding | C2220 - Aust StateTerritoryLocal - Other |
| Category | 2220 |
| UON | Y |
20188 grants / $591,562
HMRI MRSP Infrastructure Funding Cancer Program 2018$183,208
Funding body: NSW Ministry of Health
| Funding body | NSW Ministry of Health |
|---|---|
| Project Team | Conjoint Professor Stephen Ackland, Professor Xu Dong Zhang, Laureate Professor Rodney Scott, Associate Professor Nikki Verrills, Doctor Peter Pockney, Doctor James Lynam, Professor Christine Paul, Professor Amanda Baker |
| Scheme | Medical Research Support Program (MRSP) |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2018 |
| GNo | G1800336 |
| Type Of Funding | C2220 - Aust StateTerritoryLocal - Other |
| Category | 2220 |
| UON | Y |
The role of microbial oxygen sensing in the development of anastomotic leaks$121,524
Funding body: Fisher & Paykel Healthcare Limited
| Funding body | Fisher & Paykel Healthcare Limited |
|---|---|
| Project Team | Associate Professor Simon Keely, Doctor Peter Pockney, Doctor Steve Smith |
| Scheme | Research Consultancy |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2019 |
| GNo | G1701624 |
| Type Of Funding | C3211 - International For profit |
| Category | 3211 |
| UON | Y |
Mary Sawyer Postgraduate Scholarship in Cancer Research$85,500
Funding body: Hunter Medical Research Institute
| Funding body | Hunter Medical Research Institute |
|---|---|
| Project Team | Dr Georgia Carroll, Associate Professor Simon Keely, Doctor Peter Pockney, Professor Marjorie Walker, Doctor Steve Smith, Doctor Andrea Mathe |
| Scheme | Postgraduate Research Scholarship |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2020 |
| GNo | G1800612 |
| Type Of Funding | C3120 - Aust Philanthropy |
| Category | 3120 |
| UON | Y |
Investigation of disease markers in asymptomatic patients with colorectal carcinoma or colonic adenomas$81,337
Funding body: Streck
| Funding body | Streck |
|---|---|
| Project Team | Doctor Matt Dun, Doctor Peter Pockney, Laureate Professor Rodney Scott |
| Scheme | Research Grant |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2019 |
| GNo | G1800707 |
| Type Of Funding | C3211 - International For profit |
| Category | 3211 |
| UON | Y |
Lignocaine Infusion in Colorectal Cancer Patient Immune Cells LICPIC Study$59,993
Funding body: Hunter New England Local Health District
| Funding body | Hunter New England Local Health District |
|---|---|
| Project Team | Doctor Peter Pockney, Doctor Stephen Smith, Doctor Steve Smith |
| Scheme | Research Funding |
| Role | Lead |
| Funding Start | 2018 |
| Funding Finish | 2019 |
| GNo | G1801298 |
| Type Of Funding | C2220 - Aust StateTerritoryLocal - Other |
| Category | 2220 |
| UON | Y |
Analysis of luminal bacteria at the site of colorectal anastomoses and their association with anastomotic leaks$20,000
Funding body: Hunter Medical Research Institute
| Funding body | Hunter Medical Research Institute |
|---|---|
| Project Team | Associate Professor Simon Keely, Doctor Peter Pockney, Doctor Steve Smith, Associate Professor Ian Grainge, Doctor Andrea Mathe |
| Scheme | Project Grant |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2018 |
| GNo | G1701630 |
| Type Of Funding | C3120 - Aust Philanthropy |
| Category | 3120 |
| UON | Y |
A novel minimally invasive assay to identify patients with bowel cancer$20,000
Funding body: Hunter Medical Research Institute
| Funding body | Hunter Medical Research Institute |
|---|---|
| Project Team | Doctor Peter Pockney, Laureate Professor Rodney Scott |
| Scheme | Project Grant |
| Role | Lead |
| Funding Start | 2018 |
| Funding Finish | 2018 |
| GNo | G1800199 |
| Type Of Funding | C3120 - Aust Philanthropy |
| Category | 3120 |
| UON | Y |
Proteo Genomics for Screening Bowel Cancer$20,000
Funding body: Hunter New England Local Health District
| Funding body | Hunter New England Local Health District |
|---|---|
| Project Team | Doctor Peter Pockney, Laureate Professor Rodney Scott |
| Scheme | Research Funding |
| Role | Lead |
| Funding Start | 2018 |
| Funding Finish | 2020 |
| GNo | G1801085 |
| Type Of Funding | C2220 - Aust StateTerritoryLocal - Other |
| Category | 2220 |
| UON | Y |
20173 grants / $201,000
Improving access to colonoscopy by targeted waitlist management$141,000
Funding body: Cancer Institute of NSW
| Funding body | Cancer Institute of NSW |
|---|---|
| Project Team | C/Professor Jon Gani, C A/Prof Tony Proietto, Dr R Foster, Ms D Gillies, Mrs J Lack |
| Scheme | Innovations in Cancer Control Grants |
| Role | Lead |
| Funding Start | 2017 |
| Funding Finish | 2018 |
| GNo | |
| Type Of Funding | Grant - Aust Non Government |
| Category | 3AFG |
| UON | N |
HCRA Infrastructure Funding$40,000
Funding body: Hunter Cancer Research Alliance (HCRA)
| Funding body | Hunter Cancer Research Alliance (HCRA) |
|---|---|
| Scheme | .... |
| Role | Lead |
| Funding Start | 2017 |
| Funding Finish | 2017 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
The Impact of Surgery, Inflammation and Sepsis on Neutrophil Extracellular Trap (NET) Formation and Subsequent Metastatic Disease in Colorectal Cancer$20,000
Funding body: John Hunter Charitable Trust Grant
| Funding body | John Hunter Charitable Trust Grant |
|---|---|
| Scheme | John Hunter Charitable Trust Grant |
| Role | Lead |
| Funding Start | 2017 |
| Funding Finish | 2017 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
20162 grants / $111,200
Improving Access to Colonoscopy for Diagnosis of Symptomatic Patients at High Risk of Colorectal Cancer (CRD) in HNE LHD$90,000
Funding body: Cancer Instititue NSW
| Funding body | Cancer Instititue NSW |
|---|---|
| Scheme | Innovation Grant |
| Role | Lead |
| Funding Start | 2016 |
| Funding Finish | 2016 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
A Propective Observational Study of CRP Velocity in Suspected Acute Appendicitis$21,200
Funding body: John Hunter Charitable Trust Grant
| Funding body | John Hunter Charitable Trust Grant |
|---|---|
| Scheme | John Hunter Charitable Trust Grant |
| Role | Lead |
| Funding Start | 2016 |
| Funding Finish | 2016 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
20132 grants / $72,220
Introduction of Streamlined Access Pathways for Potential Colorectal Cancer Cases in the Lower Hunter$50,000
Funding body: Cancer Institute NSW
| Funding body | Cancer Institute NSW |
|---|---|
| Scheme | Evidence to Practice Grant |
| Role | Lead |
| Funding Start | 2013 |
| Funding Finish | 2013 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
A Phase 3 Randomised, Double Blind, Placebo Controlled Pragmatic Trial to Assess the Efficacy of Tranexamic Acid in Reducing the Blood Loss in Patients with Per Rectal Bleeding$22,220
Funding body: John Hunter Charitable Trust Grant
| Funding body | John Hunter Charitable Trust Grant |
|---|---|
| Scheme | John Hunter Charitable Trust Grant |
| Role | Lead |
| Funding Start | 2013 |
| Funding Finish | 2013 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
20121 grants / $20,000
Standardisation of Operative Equipment and Techniques for Common Acute General Surgery Operations$20,000
Funding body: Hunter New England LHD, NSW Health
| Funding body | Hunter New England LHD, NSW Health |
|---|---|
| Scheme | Innovation Support Scholarship |
| Role | Lead |
| Funding Start | 2012 |
| Funding Finish | 2012 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
20111 grants / $30,000
Donation to Support CNC GI Clinical Research Position$30,000
Funding body: Hunter New England LHD, NSW Health
| Funding body | Hunter New England LHD, NSW Health |
|---|---|
| Scheme | Division of Surgery |
| Role | Lead |
| Funding Start | 2011 |
| Funding Finish | 2011 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
1 grants / $48,656
Providing tailored web-based information to support colorectal cancer patients in their preparation for and recovery from surgery: A feasibility study$48,656
Funding body: Cancer Institute NSW
| Funding body | Cancer Institute NSW |
|---|---|
| Project Team | Laureate Professor Robert Sanson-Fisher, Doctor Steve Smith, Doctor Sancha Robinson, Ms Gill Batt, Conjoint Professor Frans Henskens, Conjoint Associate Professor Ross Kerridge, Doctor Christopher Oldmeadow, Doctor Peter Pockney, Doctor Christopher Hayes |
| Scheme | Evidence to Practice Grant |
| Role | Investigator |
| Funding Start | |
| Funding Finish | |
| GNo | G1300868 |
| Type Of Funding | Other Public Sector - State |
| Category | 2OPS |
| UON | Y |
Research Supervision
Number of supervisions
Current Supervision
| Commenced | Level of Study | Research Title | Program | Supervisor Type |
|---|---|---|---|---|
| 2018 | PhD | The Role of Microbial Oxygen Sensing in the Development of Anastomotic Leaks | PhD (Human Physiology), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
| 2018 | PhD | The Introduction of an Emergency Laparotomy Audit in Australia | PhD (Surgical Science), Faculty of Health and Medicine, The University of Newcastle | Principal Supervisor |
| 2018 | PhD | Proteomic Analysis of Blood Based Biomarkers for the Early Detection of Colorectal Heoplasia | PhD (Medical Biochemistry), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
| 2018 | PhD | The Functional Effects of CD36 Polymorphisms in Colorectal Cancer | PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
| 2018 | Masters | ProNGF as a Urinary Biomarker for Prostate Cancer? | M Philosophy(Surgical Science), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
| 2018 | PhD | Microbiome of Surgical Site | PhD (Anatomy), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
| 2017 | PhD | Circulating Tumour DNA as a Novel Biomarker for Colorectal Cancer | PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
| 2017 | PhD | The Impact of Surgery, Inflammation and Sepsis on Neutrophil Extracellular Trap (NET) Formation and Subsequent Metastatic Disease in Colorectal Cancer | PhD (Surgical Science), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
| 2017 | PhD | Nerve Dependence in Human Cancers | PhD (Medicine), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
Past Supervision
| Year | Level of Study | Research Title | Program | Supervisor Type |
|---|---|---|---|---|
| 2018 | Masters |
Morbidity and Mortality of Colonoscopies in the Hunter New England Region Masters degree in Surgical Sciences by distance learning, final year consists of a supervised research program leading through project design, interim reports and progress poster presentation to a final thesis submitted for assessment |
Surgery, University of Edinburgh | Principal Supervisor |
| 2016 | Masters |
A Potential Modifier Gene in Familial Adenosis Polyposis This was a project that examined the genes of patients with FAP looking for evidence of modifier genes that affect the age of onset of polyposis and of developing cancer in patients with FAP. |
Genetics, University of Edinburgh | Co-Supervisor |
| 2014 | Masters |
Haemorhoid Goligher grade versus symptom severity This was a pilot study of the correlation of patient reported symptoms compared to surgeon assessed clinical severity. |
Surgery, The University of Sydney | Principal Supervisor |
| 2014 | Honours |
Development of a Novel CO2 Insulflation Device for Laparotomy This was an honours student project that developed a device that provided a constant infusion of CO2 to the wound edge in an animal model of a laparotomy wound, with the long term aim of developing a device that can reduce the incidence of aerobic infections in surgical wounds. |
Surgery, NEWCASTLE UNIVERSITY | Co-Supervisor |
| 2013 | Honours |
A randomised clinical trial to assess the efficacy of bolus vs infusion as a mode of delivery for local anaesthetic blocks following abdominal surgery This was a randomised clinical trial of two methods of delivery of local anaesthetic to manage post-operative pain in patients who underwent abdominal surgery. The trial showed a modest difference in favour of bolus delivery. The trial included 120 patients. It has been presented at the Royal Australasian College of Surgeons Annual Scientific Meeting in 2015 |
Surgery, NEWCASTLE UNIVERSITY | Co-Supervisor |
Dr Peter Pockney
Position
Senior Lecturer
School of Medicine and Public Health
Faculty of Health and Medicine
Focus area
Medicine
Contact Details
| peter.pockney@newcastle.edu.au | |
| Phone | (02) 4985 5527 |
| Fax | (02) 4921 4274 |
Office
| Building | . |
|---|---|
| Location | John Hunter Hospital, Newcastle , |
